Management of submacular hemorrhage with intravitreal sulfur hexafluoride: A pilot study

Canadian Journal of Ophthalmology

Volumn 34, Issue 6-7, 1999, Pages 385-388

  Daneshvar, Hossein ^a   Kertes, Peter J ^a   Leonard, Brian C ^a   Peyman, Gholam A ^b  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b LSU EYE CENTER   (United States)

Author keywords

Age related macular degeneration; Intravitreal gas; Intravitreal sulfur hexafluoride; Macular degeneration; Neovascularization; Subfoveal hemorrhage; Submacular hemorrhage; Subretinal hemorrhage

Indexed keywords

DIAGNOSTIC AGENT; INDOCYANINE GREEN; SULFUR HEXAFLUORIDE;

ARTICLE; BODY POSTURE; COMPARATIVE STUDY; DRUG EFFECT; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; HUMAN; INJECTION; PATHOLOGY; PILOT STUDY; RETINA HEMORRHAGE; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; INDOCYANINE GREEN; INJECTIONS; MACULA LUTEA; MACULAR DEGENERATION; PILOT PROJECTS; PRONE POSITION; RETINAL HEMORRHAGE; SULFUR HEXAFLUORIDE; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 0033249714     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol 1997;42:195-213.
2. Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, et al. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol 1995;113:62-9.
3. Heriot WJ. Further experience in management of submacular hemorrhage with intravitreal tPA. In: Proceedings of the 1997 Update on Macular Surgery. San Francisco: American Academy of Ophthalmology; 1997. p. 82-4.
4. Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990;108:259-63.
5. Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol 1991;109:718-22.
6. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-32.
7. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-68.
8. Misono K, Kamei M, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits [abstract]. Invest Ophthalmol Vis Sci 1999;40:S712.
9. Boone DE, Boldt HC, Ross RD, Folk JC, Kimura AE. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina 1996;16:518-24.